Jon H. Come

1.8k total citations · 1 hit paper
18 papers, 1.4k citations indexed

About

Jon H. Come is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Jon H. Come has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Organic Chemistry and 2 papers in Oncology. Recurrent topics in Jon H. Come's work include Protein Kinase Regulation and GTPase Signaling (6 papers), Prion Diseases and Protein Misfolding (3 papers) and Melanoma and MAPK Pathways (3 papers). Jon H. Come is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (6 papers), Prion Diseases and Protein Misfolding (3 papers) and Melanoma and MAPK Pathways (3 papers). Jon H. Come collaborates with scholars based in United States and Poland. Jon H. Come's co-authors include Peter T. Lansbury, P. E. Fraser, David A. Kocisko, Bruce Chesebro, Byron Caughey, Gregory J. Raymond, Suzette A. Priola, Upul K. Bandarage, B. Govinda Rao and Ken S. Feldman and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Jon H. Come

17 papers receiving 1.3k citations

Hit Papers

Cell-free formation of protease-resistant prion protein 1994 2026 2004 2015 1994 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon H. Come United States 12 1.2k 541 395 192 150 18 1.4k
Peter‐Christian Klöhn United Kingdom 14 1.1k 1.0× 534 1.0× 350 0.9× 212 1.1× 15 0.1× 20 1.2k
Isabelle Huvent France 21 779 0.7× 72 0.1× 75 0.2× 489 2.5× 27 0.2× 38 1.2k
Pravas Kumar Baral Canada 11 394 0.3× 159 0.3× 121 0.3× 88 0.5× 16 0.1× 15 527
Suzana Aulić Italy 14 351 0.3× 98 0.2× 38 0.1× 135 0.7× 48 0.3× 24 618
G. G. Glenner United States 11 881 0.8× 51 0.1× 87 0.2× 537 2.8× 26 0.2× 16 1.2k
Déborah Tribouillard‐Tanvier France 15 705 0.6× 105 0.2× 56 0.1× 56 0.3× 20 0.1× 36 843
Giorgia De Franceschi Italy 11 417 0.4× 43 0.1× 63 0.2× 196 1.0× 26 0.2× 12 777
Roland Schmucki Switzerland 13 281 0.2× 96 0.2× 61 0.2× 30 0.2× 33 0.2× 21 617
F.‐Nora Vögtle Germany 28 2.2k 1.8× 26 0.0× 67 0.2× 233 1.2× 19 0.1× 45 2.5k
M. Schwalbe Germany 11 497 0.4× 34 0.1× 19 0.0× 257 1.3× 43 0.3× 12 674

Countries citing papers authored by Jon H. Come

Since Specialization
Citations

This map shows the geographic impact of Jon H. Come's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon H. Come with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon H. Come more than expected).

Fields of papers citing papers by Jon H. Come

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon H. Come. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon H. Come. The network helps show where Jon H. Come may publish in the future.

Co-authorship network of co-authors of Jon H. Come

This figure shows the co-authorship network connecting the top 25 collaborators of Jon H. Come. A scholar is included among the top collaborators of Jon H. Come based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon H. Come. Jon H. Come is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bandarage, Upul K., John J. Court, Huai Gao, et al.. (2020). ROCK inhibitors 4: Structure-activity relationship studies of 7-azaindole-based rho kinase (ROCK) inhibitors. Bioorganic & Medicinal Chemistry Letters. 33. 127721–127721. 10 indexed citations
2.
Bandarage, Upul K., Alex M. Aronov, Jingrong Cao, et al.. (2020). Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ Inhibitors. ACS Medicinal Chemistry Letters. 12(1). 129–135. 12 indexed citations
3.
Bandarage, Upul K., Jingrong Cao, Jon H. Come, et al.. (2018). ROCK inhibitors 3: Design, synthesis and structure-activity relationships of 7-azaindole-based Rho kinase (ROCK) inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(15). 2622–2626. 25 indexed citations
4.
Bandarage, Upul K., Brian Hare, Jonathan D. Parsons, et al.. (2009). 4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Potent and selective p70S6 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(17). 5191–5194. 21 indexed citations
5.
Rao, B. Govinda, Upul K. Bandarage, Tiansheng Wang, et al.. (2007). Novel thiol-based TACE inhibitors: Rational design, synthesis, and SAR of thiol-containing aryl sulfonamides. Bioorganic & Medicinal Chemistry Letters. 17(8). 2250–2253. 26 indexed citations
6.
Bandarage, Upul K., Tiansheng Wang, Jon H. Come, et al.. (2007). Novel thiol-based TACE inhibitors. Part 2: Rational design, synthesis, and SAR of thiol-containing aryl sulfones. Bioorganic & Medicinal Chemistry Letters. 18(1). 44–48. 31 indexed citations
7.
Rao, B. Govinda, Upul K. Bandarage, Tiansheng Wang, et al.. (2007). Novel Thiol‐Based TACE Inhibitors: Rational Design, Synthesis, and SAR of Thiol‐Containing Aryl Sulfonamides.. ChemInform. 38(35). 1 indexed citations
8.
Bandarage, Upul K., Jon H. Come, & Jeremy Green. (2006). Convenient synthesis of N-(4-(2-aminopyridin-4-yl)thiazol-2-yl)-2-phenylacetamides. Tetrahedron Letters. 47(46). 8079–8081. 7 indexed citations
9.
Becker, Frank, Krishna K. Murthi, Chase C. Smith, et al.. (2004). A Three-Hybrid Approach to Scanning the Proteome for Targets of Small Molecule Kinase Inhibitors. Chemistry & Biology. 11(2). 211–223. 95 indexed citations
10.
Reitz, Allen B., Michael Goodman, Barbara L. Pope, et al.. (1994). Small-Molecule Immunostimulants. Synthesis and Activity of 7,8-Disubstituted Guanosines and Structurally Related Compounds. Journal of Medicinal Chemistry. 37(21). 3561–3578. 46 indexed citations
11.
Kocisko, David A., Jon H. Come, Suzette A. Priola, et al.. (1994). Cell-free formation of protease-resistant prion protein. Nature. 370(6489). 471–474. 694 indexed citations breakdown →
12.
Chen, Robert, Michael Goodman, Dennis Argentieri, et al.. (1994). Guanosine Derivatives as Immunostimulants. Discovery of Loxoribine. Nucleosides and Nucleotides. 13(1-3). 551–562. 3 indexed citations
13.
Come, Jon H. & Peter T. Lansbury. (1994). Predisposition of prion protein homozygotes to Creutzfeldt-Jakob disease can be explained by a nucleation-dependent polymerization mechanism. Journal of the American Chemical Society. 116(9). 4109–4110. 25 indexed citations
14.
Come, Jon H., P. E. Fraser, & Peter T. Lansbury. (1993). A kinetic model for amyloid formation in the prion diseases: importance of seeding.. Proceedings of the National Academy of Sciences. 90(13). 5959–5963. 329 indexed citations
15.
Come, Jon H., et al.. (1991). Synthesis of Novel 7‐Allyl‐8‐Substituted Guanosines. Journal of the Chinese Chemical Society. 38(5). 497–499. 1 indexed citations
16.
Come, Jon H., et al.. (1991). A convenient synthesis of 7-allyl-8-substituted guanosines. Tetrahedron Letters. 32(37). 4823–4826. 4 indexed citations
17.
Feldman, Ken S., et al.. (1989). Mechanistic and preparative studies of the intramolecular photocyclization of methylated 2-(4-pentenyl)tropones. The Journal of Organic Chemistry. 54(3). 592–601. 28 indexed citations
18.
Feldman, Ken S., et al.. (1986). Synthesis of eight-membered carbocycles via intramolecular [6.pi. + 2.pi.] photocycloaddition of alkenyl tropones. Journal of the American Chemical Society. 108(6). 1327–1328. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026